NGNE
NGNE
NASDAQ · Biotechnology

Neurogene Inc

$17.23
+0.86 (+5.25%)
As of Feb 8, 2:01 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +45.9% upside
Low Target $17.03
Average Target $25.14
High Target $37.02
Current Price $17.23
Current
$17.23
Target
$25.14
$17.03 $25.14 avg $37.02
Scenario Analysis
Bear Case
$17.03
-1.2%
Low target
Base Case
$25.14
+45.9%
Avg target
Bull Case
$37.02
+114.9%
High target
Risk/Reward
99.0x
Highly favorable
Price in Context
52-Week High
$32.35
-46.7% from high
52-Week Low
$13.80
+24.9% from low
Target vs 52W High
$25.14
-22.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%